224 related articles for article (PubMed ID: 20888833)
1. β₂ AR agonists in treatment of chronic heart failure: long path to translation.
Talan MI; Ahmet I; Xiao RP; Lakatta EG
J Mol Cell Cardiol; 2011 Oct; 51(4):529-33. PubMed ID: 20888833
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor.
Ahmet I; Morrell C; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2009 Oct; 331(1):178-85. PubMed ID: 19587314
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.
Ahmet I; Lakatta EG; Talan MI
Heart Fail Rev; 2005 Dec; 10(4):289-96. PubMed ID: 16583177
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F
J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
[TBL] [Abstract][Full Text] [Related]
7. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP
J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315
[TBL] [Abstract][Full Text] [Related]
8. Fenoterol enantiomers do not possess beneficial therapeutic properties of their racemic mixture in the rat model of post myocardial infarction dilated cardiomyopathy.
Ahmet I; Turner T; Lakatta EG; Talan MI
Cardiovasc Drugs Ther; 2012 Apr; 26(2):101-8. PubMed ID: 22328006
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure.
Okafor CC; Perreault-Micale C; Hajjar RJ; Lebeche D; Skiroman K; Jabbour G; Doye AA; Lee MX; Laste N; Gwathmey JK
BMC Physiol; 2003 Jul; 3():6. PubMed ID: 12873352
[TBL] [Abstract][Full Text] [Related]
10. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
[TBL] [Abstract][Full Text] [Related]
11. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
[TBL] [Abstract][Full Text] [Related]
12. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular reverse remodeling with infantile dilated cardiomyopathy and pitfalls of carvedilol therapy.
Tsuda E; Negishi J; Noritake K; Iwasa T; Abe T
J Cardiol; 2016 Feb; 67(2):147-52. PubMed ID: 26572957
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation.
Zhan DY; Morimoto S; Du CK; Wang YY; Lu QW; Tanaka A; Ide T; Miwa Y; Takahashi-Yanaga F; Sasaguri T
Cardiovasc Res; 2009 Oct; 84(1):64-71. PubMed ID: 19477965
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.
Böhm M; Ettelbrück S; Flesch M; van Gilst WH; Knorr A; Maack C; Pinto YM; Paul M; Teisman AC; Zolk O
Cardiovasc Res; 1998 Oct; 40(1):146-55. PubMed ID: 9876327
[TBL] [Abstract][Full Text] [Related]
16. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
17. Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy.
Cinquegrana G; D'Aniello L; Landi M; Spinelli L; Grande G; De Prisco F; Petretta M
J Card Fail; 2005 Apr; 11(3):213-9. PubMed ID: 15812750
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol: a review of its use in chronic heart failure.
Keating GM; Jarvis B
Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
[TBL] [Abstract][Full Text] [Related]
19. What type of beta-blocker should be used to treat chronic heart failure?
Bristow MR
Circulation; 2000 Aug; 102(5):484-6. PubMed ID: 10920055
[No Abstract] [Full Text] [Related]
20. Sympathetic activation and the role of beta-blockers in chronic heart failure.
Krum H
Aust N Z J Med; 1999 Jun; 29(3):418-27. PubMed ID: 10868514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]